Search

The FDA has approved nirogacestat (OgsiveoTM), a targeted therapy for desmoid tumors. A recent phase 3 clinical trial found that the drug significantly shrank desmoid tumors in 41% of patients. Desmoid tumors (also known as aggressive fibromatosis) are a rare type of soft tissue tumor.

… Tuesday, November 28, 2023 Update: On November 27, 2023, the U.S. Food and Drug Administration approved nirogacestat (Ogsiveo™) for adults with desmoid tumors that cannot be treated with surgery alone. The approval was based on research led by investigators at Memorial Sloan Kettering Cancer Center.

Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack.

… Tuesday, May 8, 2012 Women on Long Island who don’t have insurance or who are underinsured may be able to take advantage of free mammograms at Memorial Sloan Kettering Cancer Center Commack . The Center has contracted with the New York State Cancer Services Program (CSP) of Western Suffolk County to

MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers.

… Wednesday, June 7, 2023 Highlights MSK-led research found an unexpected link between chromosomal instability and epigenetic alternations, both of which are hallmarks of cancer — especially advanced, drug-resistant cancers. Together these defects lead to differences between individual cancer cells within

Doctors and scientists at MSK are desperately trying to figure out why more young patients like Rebecca, 33, are getting colorectal cancer — and how best to treat them.

… Friday, January 1, 2021 A disturbing question lies at the heart of a common and deadly cancer. Why is colorectal cancer striking more people as young as their 20s and 30s — and even teenagers? Most of these young people have no family history of the disease. They also have few of the risk factors associated

Los médicos y científicos de MSK están tratando desesperadamente de descubrir por qué más pacientes jóvenes como Rebecca, de 33 años, padecen cáncer colorrectal, y cuál es la mejor manera de tratarlos.

… Friday, January 1, 2021 Rebecca Lerner, paciente del Memorial Sloan Kettering, sonriendo en el hospital. ¿Por qué el cáncer colorrectal está afectando a más personas de entre 20 y 30 años, e incluso a adolescentes? La mayoría de estos jóvenes no tienen antecedentes familiares de la enfermedad. También

Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies.

… Monday, December 1, 2008 Summary Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies. Charles L. Sawyers has been elected a member of the Institute of Medicine of the National Academies. Dr. Sawyers is a nationally recognized physician-scientist who joined

Meet Christopher Jeter, who was diagnosed nearly 10 years ago with lung cancer. He was successfully treated at Memorial Sloan Kettering and now is being closely monitored by experts in MSK's Adult Survivorship Program.

… Monday, June 14, 2021 Getting hit by a bus saved Christopher Jeter’s life. In 2011, when the 54-year-old inventory manager took his brand-new motorcycle for a spin, he collided with a public transit bus. Incredibly, he left the scene mostly unscathed. But doctors in the emergency room near his home in

Conozca a Christopher Jeter, quien fue diagnosticado hace casi 10 años con cáncer pulmonar. Fue tratado con éxito en Memorial Sloan Kettering y ahora está siendo monitoreado de cerca por expertos en el Programa de Sobrevivencia para Adultos de MSK.

… Monday, June 14, 2021 Ser atropellado por un autobús le salvó la vida a Christopher Jeter. En 2011, cuando el gerente de inventario de 54 años salió a probar su motocicleta nueva, chocó con un autobús de transporte público. Increíblemente, salió del accidente casi ileso. Pero los médicos en la sala de

Results from a clinical trial indicate that an experimental CAR therapy for mesothelioma is safe.

… Sunday, March 31, 2019 Summary Scientists at Memorial Sloan Kettering are investigating ways to develop effective CAR T cell therapies for solid tumors. Results from a clinical trial in people with mesothelioma indicate that an experimental CAR therapy is safe and may provide benefit to patients, especially

Collaboration leads to a new digital pathology tool that allows some doctors to diagnose patient tumors from home.

… Monday, September 21, 2020 Summary MSK’s Pathology Department has developed new digital technologies to keep its workers safe without having to compromise patient care — allowing some of its doctors to work from home. During the COVID-19 pandemic, Memorial Sloan Kettering doctors and nurses have been